What are the recommended treatment regimens for syphilis by stage and special situations such as pregnancy and penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment Guidelines

Benzathine penicillin G remains the only proven effective treatment for all stages of syphilis, with dosing and duration determined by disease stage. 1

Treatment by Disease Stage

Primary, Secondary, and Early Latent Syphilis (infection <1 year)

  • Administer benzathine penicillin G 2.4 million units IM as a single dose. 1
  • This regimen achieves 90-100% treatment success rates for early syphilis. 2
  • Serologic follow-up should occur at 6 and 12 months after treatment. 1

Late Latent Syphilis (infection >1 year or unknown duration)

  • Administer benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units). 1
  • Before initiating treatment, evaluate for neurologic or ocular symptoms; if present, perform CSF examination and treat as neurosyphilis. 1
  • Serologic monitoring should occur at 6,12,18, and 24 months post-treatment. 1

Neurosyphilis, Ocular Syphilis, or Otic Syphilis

  • Administer aqueous crystalline penicillin G 18-24 million units per day (given as 3-4 million units IV every 4 hours) for 10-14 days. 1
  • Alternative regimen: procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily, both for 10-14 days. 1
  • Consider adding benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing the neurosyphilis regimen to provide comparable total duration. 1
  • If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes. 1

Special Populations

Pregnancy

Pregnant women with syphilis must receive penicillin therapy appropriate for their disease stage—there are no acceptable alternatives. 1, 3, 4

  • For primary, secondary, or early latent syphilis: benzathine penicillin G 2.4 million units IM as a single dose. 4
  • Some experts recommend an additional dose of 2.4 million units IM one week after the initial dose, particularly in the third trimester or for women with secondary syphilis. 5, 4
  • For late latent or unknown duration syphilis: benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM each at weekly intervals. 4
  • Treatment must occur >4 weeks before delivery for optimal outcomes. 1

Critical Pregnancy Considerations

  • All pregnant women should be screened for syphilis at the first prenatal visit. 4
  • In high-risk populations, perform additional screening at 28-32 weeks gestation and at delivery. 4
  • Repeat serologic titers in the third trimester and at delivery; check monthly in high-risk women. 4
  • Women treated in the second half of pregnancy are at risk for premature labor or fetal distress if Jarisch-Herxheimer reaction occurs; advise them to seek immediate care if they notice contractions or decreased fetal movements within 24 hours of treatment. 5, 4
  • Treatment should never be delayed due to concerns about Jarisch-Herxheimer reaction—untreated syphilis poses far greater fetal harm. 4
  • No newborn should be discharged without documented maternal syphilis screening at least once during pregnancy. 5, 4

Penicillin Allergy in Pregnancy

Pregnant women with penicillin allergy must undergo desensitization and then receive penicillin—no alternatives are acceptable for preventing congenital syphilis. 1, 3, 4

  • Tetracyclines cause maternal hepatotoxicity and fetal bone/tooth staining and are absolutely contraindicated. 5, 3, 4
  • Erythromycin does not reliably cure fetal infection and should never be used. 5, 3, 4
  • Skin testing followed by desensitization is mandatory before penicillin administration. 5, 4

Penicillin Allergy in Non-Pregnant Patients

For non-pregnant, penicillin-allergic patients with early syphilis (primary, secondary, or early latent), doxycycline 100 mg orally twice daily for 2 weeks is the preferred alternative. 5, 1

  • Alternative: tetracycline 500 mg orally four times daily for 2 weeks. 5
  • For late latent syphilis: doxycycline 100 mg orally twice daily for 4 weeks OR tetracycline 500 mg orally four times daily for 4 weeks. 1
  • CSF examination must exclude neurosyphilis before using non-penicillin therapy. 1
  • Close follow-up is essential as these alternatives have less clinical experience and documented effectiveness. 5
  • Ceftriaxone has insufficient data; erythromycin is less effective than other regimens. 5
  • Azithromycin is not recommended due to widespread resistance. 1

HIV-Infected Patients

HIV-positive individuals should receive the same penicillin regimens as HIV-negative patients for all disease stages. 1

  • More intensive monitoring is required: clinical and serological evaluation at 3,6,9,12, and 24 months after treatment. 1
  • Failure to achieve a fourfold decrease in nontreponemal titers within 3 months for primary/secondary syphilis indicates treatment failure. 1
  • When treatment failure occurs with normal CSF, retreat with benzathine penicillin G 7.2 million units (three weekly doses of 2.4 million units each). 1
  • Consider CSF examination for late latent syphilis in HIV-infected patients to exclude neurosyphilis before treatment. 1
  • One study found that adding doxycycline 100 mg orally twice daily for 7 days to single-dose benzathine penicillin G improved serologic response rates in HIV-infected patients with early syphilis (79.5% vs 70.3%). 6

Monitoring Treatment Response

Definition of Treatment Success

  • A fourfold (two-dilution) decline in nontreponemal test titers indicates successful treatment. 1
  • For primary/secondary syphilis, this decline should occur by 6 months; for latent syphilis, by 12-24 months. 1, 2

Indicators of Treatment Failure

  • A fourfold increase in titers. 1
  • An initial titer ≥1:32 that does not fall fourfold within 12-24 months. 1
  • Development of new clinical signs or symptoms attributable to syphilis. 1
  • When treatment failure is suspected, perform CSF examination and consider retreatment. 1

Important Testing Considerations

  • Sequential RPR tests should use the same method and ideally the same laboratory, as RPR titers are often slightly higher than VDRL titers and cannot be directly compared. 1
  • HIV-infected patients may have atypical serologic responses (unusually high, low, or fluctuating titers), but this does not change treatment. 1

Additional Management Considerations

Partner Management

  • Presumptively treat sexual partners exposed within 90 days preceding diagnosis, even if seronegative. 1
  • Long-term sexual partners of patients with late syphilis should be clinically and serologically evaluated. 4

HIV Testing

  • All patients diagnosed with syphilis should be tested for HIV if their status is unknown. 1

Jarisch-Herxheimer Reaction

  • Warn all patients about this acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment. 1
  • This is particularly important for pregnant women in the second half of pregnancy. 5, 4

Common Pitfalls to Avoid

  • Never use non-penicillin regimens in pregnancy—desensitization is mandatory if penicillin-allergic. 1, 3, 4
  • Do not delay treatment in pregnancy due to fear of Jarisch-Herxheimer reaction. 4
  • Do not compare titers between different test types (RPR vs VDRL). 1
  • Do not use serologic titers alone to differentiate early from late latent syphilis when determining treatment duration. 1
  • Do not discharge newborns without documented maternal syphilis screening. 5, 4

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Penicillin as the Cornerstone of Managing Tooth Abscess and Syphilis in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Syphilis Treatment in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.